Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.35 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.33 |
| ▸ | HPGDS | O60760 | 2/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CCR1 | P32246 | 2/20 | 0.31 |
| ▸ | CCR5 | P51681 | 2/20 | 0.31 |
| ▸ | CCR8 | P51685 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12247266 | 0.93 | HTR2C (0.39) | HTR2CKDM4ETP53MAPK1SMN1; SMN2 | |
| SCHEMBL13459686 | 0.93 | HTR2C (0.39) | HTR2CKDM4ETP53MAPK1SMN1; SMN2 | |
| SCHEMBL12247029 | 0.91 | PDK2 (0.35) | PDK2HPGDSGABRA1GABRG2GABRB3 | |
| SCHEMBL12247026 | 0.90 | PDK2 (0.33) | KDM4ESMN1; SMN2NPC1ALDH1A1HPGD | |
| SCHEMBL12247018 | 0.89 | HPGDS (0.37) | MAPK1HSD17B10PDK2TGFBR1HPGDS | |
| SCHEMBL12247027 | 0.89 | PDK2 (0.40) | HTR2CKDM4ETP53SMN1; SMN2NPC1 | |
| SCHEMBL12247010 | 0.88 | KDM4E (0.37) | KDM4ETP53SMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL12247011 | 0.87 | HPGDS (0.39) | KDM4ETP53MAPK1SMN1; SMN2NPC1 | |
| SCHEMBL12247022 | 0.87 | HPGDS (0.37) | KDM4ETP53MAPK1SMN1; SMN2ALDH1A1 | |
| SCHEMBL12247016 | 0.86 | HPGDS (0.39) | KDM4ETP53MAPK1SMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8525158-B2 | Anthracene derivative and organic electroluminescence element using the same | DOOSAN CORPORATION (KR) | 2013-09-03 | — | — | US | disclosed |
| US-8525158-B2 | Anthracene derivative and organic electroluminescence element using the same | DOOSAN CORPORATION (KR) | 2013-09-03 | — | — | US | disclosed |
| US-20110210320-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME | DOOSAN CORPORATION (KR) | 2011-09-01 | — | — | US | disclosed |
| US-20110210320-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME | DOOSAN CORPORATION (KR) | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110210320-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME | KCNJ2, KCNJ1, BRD4 | HTR2C 3096/4885KDM4E 913/4885TP53 1074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.